PHARMACOSMOS A/S: Financial statements 2025
CVR: 15517085
Source: annual report 2025, Danish Business Authority
01/05/2024 – 30/04/2025
PHARMACOSMOS A/S (CVR 15517085) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 2,623,000,000 and a net result of DKK 1,622,000,000 compared with DKK 789,701,000 the year before. That is an increase of 62.6% compared with the year before. The profit margin was 61.8%. Equity in the 2025 report amounted to DKK 2,197,000,000. The solvency ratio was 46.5%. The company had 240 employees in the financial year.
- Revenue
- DKK 2,623,000,000
- Gross Profit
- DKK 2,093,000,000
- Profit/Loss
- DKK 1,622,000,000
- Equity
- DKK 2,197,000,000
- Total Assets
- DKK 4,723,000,000
- Employees
- 240
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 2.6B | 2.1B | 1.6B | 2.2B | 240 |
| 2024 | 1.6B | 1.2B | 789.7M | 1.6B | 208 |
| 2023 | 1.1B | 674.1M | 114.3M | 854.6M | 191 |
| 2022 | 876.8M | 545.5M | 170M | 807.5M | 468 |
| 2021 | 782.2M | 464.9M | -136M | 642.8M | 352 |
Official annual report
How creditworthy is PHARMACOSMOS A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
PHARMACOSMOS A/S has won the tender "Amgros 2026 1.207.a" issued by Amgros I/S worth 248,923,125 DKK.
As of September 18, 2025, Claes Christian Strøm is registered as director of PHARMACOSMOS A/S.
About PHARMACOSMOS A/S
PHARMACOSMOS A/S is a Danish company of the type Aktieselskab based in Holbæk, founded in 1991. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named PHARMACOSMOS PHARMACEUTICALS A/S and SOLOCHEM A/S. The management consists of Tobias Sidelmann Christensen, Claes Christian Strøm and Henrik Parker. The board consists of Jacob Tolstrup (chair), Lars Christensen, Lars Green and Martin Holst Lange. The company is owned by PHARMACOSMOS HOLDING A/S. The company has 327 employees (2026). In 2026, the company reported revenue of DKK 2,176,000,000 and a net result of DKK 714,000,000 compared with DKK 1,622,000,000 the year before. Equity in the 2026 report amounted to DKK 2,775,000,000.